Aurora Cannabis Inc. shares are experiencing an uptick in after-hours trading, driven by the company's recent announcement of strong fiscal 2025 second-quarter results. The company reported a record adjusted EBITDA of $10.1 million, marking a significant 210% y/y increase. Additionally, quarterly net revenue rose by 29% y/y to $81.1 million, with a notable 41% growth in global medical marijuana sales. These
Aurora Cannabis Inc. (ACB) shares are seeing an uptick in after-hours trading, potentially influenced by recent developments in the cannabis industry. A Nebraska state judge's decision to dismiss a legal challenge against medical marijuana ballot measures has paved the way for the establishment of a new cannabis market in the state. This ruling, issued on November 27, 2024, allows cannabis activists to move
Aurora Cannabis Inc. (ACB) shares are experiencing an uptick today, likely influenced by the broader positive sentiment in the cannabis market. Recent data from LeafLink, published on November 27, 2024, highlights that retail cannabis sales in the United States hit a record in October, reaching approximately $2.8 billion. This represents a 6.2% increase from the previous year, indicating a robust growth tra
Aurora Cannabis Inc. (ACB) has been a topic of discussion on Reddit forums, with users focusing on the company's recent expansion of its medical portfolio. The introduction of five new premium cannabis products has sparked mixed reactions. Some users are optimistic, with one commenting, "Looking for $50. … Moon?… $10?" However, others are less impressed, dismissing the news as a "nothing burger," noting tha